Earnings · China A-shares
Apeloa Pharmaceutical Co. Ltd. Class A (000739) earnings
Apeloa Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-22: net profit -12.37% year on year, -12.22% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -6.18% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-22
- Period end
- 2026-09-30
- Net profit YoY
- -12.37%
- Excl. one-offs YoY
- -12.22%
- Net profit QoQ
- -66.60%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.75% | — |
| 3 days | -6.18% | — |
| 7 days | -3.74% | — |
| 14 days | -2.68% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 8 reports (average -3.70%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-23 | ¥613.67M | -12.37% | -12.22% | -11.97% | 0.53 | 9.63% | -6.18% | — | — |
| 2026 interim report | 2026-08-20 | ¥522.37M | -7.22% | -4.88% | -11.41% | 0.45 | 8.05% | -10.77% | +24.01% | +29.70% |
| 2026 Q1 report | 2026-04-21 | ¥249.02M | +0.19% | +18.15% | -10.36% | 0.22 | 3.86% | +7.57% | -6.58% | -10.02% |
| 2025 annual report | 2026-03-20 | ¥890.68M | -13.62% | -21.86% | -18.62% | 0.77 | 13.22% | -6.50% | +0.28% | -6.11% |
| 2025 Q3 report | 2025-10-22 | ¥700.27M | -19.48% | -22.14% | -16.43% | 0.61 | 10.21% | -4.54% | +0.50% | +1.84% |
| 2025 interim report | 2025-08-20 | ¥563.05M | -9.89% | -13.59% | -15.31% | 0.49 | 8.10% | +0.86% | +0.49% | -9.56% |
| 2025 Q1 report | 2025-04-18 | ¥248.55M | +1.98% | -14.05% | -14.63% | 0.21 | 3.62% | +2.01% | +6.63% | +3.73% |
| 2024 annual report | 2025-03-11 | ¥1.03B | -2.29% | -4.09% | +4.77% | 0.89 | 16.09% | -12.07% | -20.55% | -15.43% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.